Skip to main content
SpringerLink
Log in

Cellular and Molecular Biology

Comment on: “Evolving roles of CD38 metabolism in solid tumour microenvironment”

  • Correspondence
  • Published:
British Journal of Cancer Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Gao L, Du X, Li J, Xiao-Feng Qin F. Evolving roles of CD38 metabolism in solid tumour microenvironment. Br J Cancer. 2022. https://doi.org/10.1038/s41416-022-02052-6.

  2. Zocchi E, Franco L, Guida L, Calder L, De Flora A. Self-aggregation of purified and membrane-bound erythrocyte CD38 induces extensive decrease of its ADP-ribosyl cyclase activity. FEBS Lett. 1995;359:35–40.

    Article  CAS  PubMed  Google Scholar 

  3. Takasawa S, Tohgo A, Noguchi N, Koguma T, Nata K, Sugimoto T, et al. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem. 1993;268:26052–4.

    Article  CAS  PubMed  Google Scholar 

  4. Tohgo A, Munakata H, Takasawa S, Nata K, Akiyama T, Hayashi N, et al. Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase. J Biol Chem. 1997;272:3879–82.

    Article  CAS  PubMed  Google Scholar 

  5. Okamoto H, Takasawa S. Recent advances in the Okamoto model: the CD38-cyclic ADP-ribose signal system and the regenerating gene protein (Reg)-Reg receptor system in β-cells. Diabetes. 2002;51:S462–73.

    Article  CAS  PubMed  Google Scholar 

  6. Takasawa S. CD38–cyclic ADP-ribose signal system in physiology, biochemistry, and pathophysiology. Int J Mol Sci. 2022;23:4306.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

    Pavel Nesmiyanov

Authors
  1. Pavel Nesmiyanov
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

PN was the single author.

Corresponding author

Correspondence to Pavel Nesmiyanov.

Ethics declarations

Competing interests

The author declares no competing interests.

Ethics approval and consent to participate

Not applicable.

Consent to publish

Not applicable.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nesmiyanov, P. Comment on: “Evolving roles of CD38 metabolism in solid tumour microenvironment”. Br J Cancer 128, 491 (2023). https://doi.org/10.1038/s41416-022-02113-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-022-02113-w

  • Springer Nature Limited

Search

Navigation